捷強裝備(300875.SZ):公司已有提供海關核輻射相關儀器設備和服務
格隆匯7月11日丨有投資者向捷強裝備(300875.SZ)提問:公司是否有接海關業務?
捷強裝備回覆:尊敬的投資者,您好!公司控股子公司上海仁機儀器儀表有限公司的產品品目涵蓋了便攜式輻射監測儀表、個人防護監測儀表、在線/固定式輻射監測儀表、實驗室測量裝置、計量標準裝置、核應急救援環境監測及輻射防護設備等6大類、40多種不同規格的核輻射監測設備。廣泛應用於環保、衞健委、醫療、安監、海關、核工業上下游系統等領域。公司已有提供海關核輻射相關儀器設備和服務。感謝您對公司的關注,謝謝!
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.